Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7703)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2015 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mlynarsky L, Menachem Y, Shibolet O. Treatment of hepatocellular carcinoma: Steps forward but still a long way to go. World J Hepatol 2015; 7(3): 566-574 [PMID: 25848480 DOI: 10.4254/wjh.v7.i3.566] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i3/566.htm |
| Number | Citing Articles |
| 1 |
Ahmed A. Ghafar, Elsayed Ghoneem, Salah Rozaik, Ahmed Akef, Metwaly Mortada. Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization. The Egyptian Journal of Internal Medicine 2019; 31(3): 254 doi: 10.4103/ejim.ejim_110_18
|
| 2 |
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance. Molecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
|
| 3 |
Ming Jia, Yulin Xiong, Maoshi Li, Qing Mao. Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2020; 28(4): 371 doi: 10.3727/096504020X15853075736554
|
| 4 |
Shujian Ge, Yali Xu, Hongliang Wang, Yaxin Sun, Xiangguo Tian, Zhixin Cao, Xiaoyan Lin, Jiawen Xu, Qiangxiu Wang. Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma. Oncology Letters 2017; 14(3): 3689 doi: 10.3892/ol.2017.6616
|
| 5 |
Zhuo Wang, Yuanliang Huang, Luanjun Tan. Downregulation of lncRNA DANCR promotes osteogenic differentiation of periodontal ligament stem cells. BMC Developmental Biology 2020; 20(1) doi: 10.1186/s12861-019-0206-8
|
| 6 |
Huazheng Shi, Ying Duan, Jie Shi, Wenrui Zhang, Weiran Liu, Bixia Shen, Fufu Liu, Xin Mei, Xiaoxiao Li, Zheng Yuan. Role of preoperative prediction of microvascular invasion in hepatocellular carcinoma based on the texture of FDG PET image: A comparison of quantitative metabolic parameters and MRI. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.928969
|
| 7 |
Jingjing Yao, Jindong Fu, Ying Liu, Wei Qu, Guangdong Wang, Zaojun Yan. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Annals of Hepatology 2021; 23: 100297 doi: 10.1016/j.aohep.2020.100297
|
| 8 |
Yan Zhao, Huina Wu, Xiaoyan Xing, Yuqian Ma, Shengping Ji, Xinyue Xu, Xin Zhao, Sensen Wang, Wenyan Jiang, Chunyan Fang, Lei Zhang, Fang Yan, Xuejian Wang. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway. Journal of Pharmacology and Experimental Therapeutics 2020; 374(3): 512 doi: 10.1124/jpet.120.265637
|
| 9 |
Maria Visalli, Marcello Bartolotta, Francesca Polito, Rosaria Oteri, Adalberto Barbera, Roberto Arrigo, Rosa Di Giorgio, Giuseppe Navarra, M'hammed Aguennouz. miRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4410
|
| 10 |
Guo-Jian Li, Qin-Yan Chen, Tim J. Harrison, Xue-Yan Wang, Li-Ping Hu, Qing-Li Yang, Kai-Wen Li, Zhong-Liao Fang. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Cancer Biomarkers 2017; 18(3): 241 doi: 10.3233/CBM-160131
|
| 11 |
Chunhui Dou, Chunyan Fang, Yan Zhao, Xiaoyan Fu, Yufei Zhang, Dongqi Zhu, Huina Wu, Huijie Liu, Jian Zhang, Wenfang Xu, Zhijun Liu, Hongyan Wang, Daqi Li, Xuejian Wang. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage. International Journal of Oncology 2017; 51(6): 1775 doi: 10.3892/ijo.2017.4159
|
| 12 |
Sarina Mokhtari, Mehran Solati-Hashjin, Zahra Khosrowpour, Mazaher Gholipourmalekabadi. Layered double hydroxide-galactose as an excellent nanocarrier for targeted delivery of curcumin to hepatocellular carcinoma cells. Applied Clay Science 2021; 200: 105891 doi: 10.1016/j.clay.2020.105891
|
| 13 |
Shengping Ji, Yuqian Ma, Xiaoyan Xing, Binbin Ge, Yutian Li, Xinyue Xu, Jiliang Song, Mei Xiao, Feng Gao, Wenyan Jiang, Chunyan Fang, Xuejian Wang. Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.660377
|
| 14 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
| 15 |
Noha M. Bakr, Ashraf Awad, Emad A. Moustafa, Ahmed M. El‐Gebaly. The association between interleukin‐21 (rs2055979G/T) gene polymorphism and the risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus. Journal of Cellular Biochemistry 2019; 120(10): 18524 doi: 10.1002/jcb.29174
|
| 16 |
Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroki Teraoku, Yuhei Waki, Chiharu Nakasu, Mitsuo Shimada. Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-022-01892-6
|
| 17 |
Liping Qu, Huiqing Zhang, Yanlong Yang, Geliang Yang, Hailiang Xin, Changquan Ling. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathwayin vitro. Pharmaceutical Biology 2016; 54(8): 1445 doi: 10.3109/13880209.2015.1104699
|
| 18 |
Yanan Song, Guoyu Wang, Juhua Zhuang, Jing Ni, Suiliang Zhang, Ying Ye, Wei Xia. MicroRNA‑584 prohibits hepatocellular carcinoma cell proliferation and invasion by directly targeting BDNF. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10424
|
| 19 |
Sun Young Yim, Ho Soo Chun, Jae Seung Lee, Ji-Hwan Lim, Tae Hyung Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Gyoung Min Kim, Jong Yun Won, Yeon Seok Seo, Yun Hwan Kim, Soon Ho Um, Do Young Kim. Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients. Cancers 2022; 14(2): 385 doi: 10.3390/cancers14020385
|
| 20 |
Seung Kak Shin, Yun Soo Kim, Seung Joon Choi, Young Sup Shim, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis. Medicine 2017; 96(29): e7278 doi: 10.1097/MD.0000000000007278
|
| 21 |
Camila C. Simoes, Swan N. Thung, Maria Isabel Fiel, Max W. Sung, Myron E. Schwartz, Stephen C. Ward. Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy. Modern Pathology 2021; 34(4): 823 doi: 10.1038/s41379-020-00679-5
|
| 22 |
Song Shen, Chun-Yang Sun, Xiao-Jiao Du, Hong-Jun Li, Yang Liu, Jin-Xing Xia, Yan-Hua Zhu, Jun Wang. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. Biomaterials 2015; 70: 71 doi: 10.1016/j.biomaterials.2015.08.026
|
| 23 |
Hongtao Wei, Xiaotong Yu, Xiaowei Xue, Hui Liu, Menglong Wang, Yingying Li, Xuejiang Wang, Huiguo Ding. Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients. Oncology Letters 2017; 14(3): 2749 doi: 10.3892/ol.2017.6545
|
| 24 |
Yossi Ventura, Brian I Carr, Issac Kori, Vito Guerra, Oren Shibolet. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World Journal of Gastroenterology 2018; 24(15): 1641-1649 doi: 10.3748/wjg.v24.i15.1641
|
| 25 |
Jae Seung Lee, Han Ah Lee, Mi Young Jeon, Tae Seop Lim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soon Ho Um, Kwang-Hyub Han, Yeon Seok Seo, Seung Up Kim. Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization. European Journal of Gastroenterology & Hepatology 2020; 32(6): 739 doi: 10.1097/MEG.0000000000001585
|
| 26 |
Youcai Li, Yin Zhang, Qi Fang, Xiaoyao Zhang, Peng Hou, Hubing Wu, Xinlu Wang. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(8): 2599 doi: 10.1007/s00259-020-05119-9
|
| 27 |
Aliya Qayyum, Ken-Pin Hwang, Jason Stafford, Anuj Verma, Dipen M. Maru, Subramanya Sandesh, Jia Sun, Roberto Carmagnani Pestana, Rony Avritscher, Manal M. Hassan, Hesham Amin, Asif Rashid, Ignacio I. Wistuba, Richard L. Ehman, Jingfei Ma, Ahmed O. Kaseb. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0766-y
|
| 28 |
Ying Wang, Chang-Long Chen, Qiu-Zhong Pan, Ying-Yuan Wu, Jing-Jing Zhao, Shan-Shan Jiang, Jie Chao, Xiao-Fei Zhang, Hong-Xia Zhang, Zi-Qi Zhou, Yan Tang, Xu-Qiong Huang, Jian-Hua Zhang, Jian-Chuan Xia. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget 2016; 7(5): 6323 doi: 10.18632/oncotarget.6319
|
| 29 |
Wenwen Zhang, Huiyan Sun, Xuefeng Shi, Hua Wang, Chunping Cui, Fengjun Xiao, ChuTse Wu, Xiaozhong Guo, Lisheng Wang. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma. Tumor Biology 2016; 37(6): 7741 doi: 10.1007/s13277-015-4406-y
|
| 30 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 31 |
J. Roller, V. Zimmer, A. Bücker, M. Glanemann, R.M. Eisele. Conservative treatment of gastric perforation after microwave ablation of a hepatocellular carcinoma. Medicine 2022; 101(22): e29195 doi: 10.1097/MD.0000000000029195
|
| 32 |
Iqbal Azad, Asif Jafri, Tahmeena Khan, Yusuf Akhter, Md Arshad, Firoj Hassan, Naseem Ahmad, Abdul Rahman Khan, Malik Nasibullah. Evaluation of pyrrole-2,3-dicarboxylate derivatives: Synthesis, DFT analysis, molecular docking, virtual screening and in vitro anti-hepatic cancer study. Journal of Molecular Structure 2019; 1176: 314 doi: 10.1016/j.molstruc.2018.08.049
|
| 33 |
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology. 2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
|
| 34 |
Yanyan Zhang, Mingming Liu, Qi Zhang, Jun Sun, Sudan Wang, Jinli Ding, Dongli Shi, Hongjun Li. MRI in the differential diagnosis between well-differentiated hepatocellular carcinomas and high-grade dysplastic nodules in cirrhotic liver. Radiology of Infectious Diseases 2020; 7(1): 22 doi: 10.1016/j.jrid.2020.03.009
|
| 35 |
Zhi-Peng Sun, Jian Zhang, Li-Hong Shi, Xiu-Rong Zhang, Yu Duan, Wen-Fang Xu, Gong Dai, Xue-Jian Wang. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. Biomedicine & Pharmacotherapy 2015; 76: 65 doi: 10.1016/j.biopha.2015.10.023
|
| 36 |
Lindsay Sobotka, Alice Hinton, Lanla Conteh. Women receive more inpatient resections and ablations for hepatocellular carcinoma than men. World Journal of Hepatology 2017; 9(36): 1346-1351 doi: 10.4254/wjh.v9.i36.1346
|
| 37 |
Seung Hyup Hyun, Jae Seon Eo, Bong-Il Song, Jeong Won Lee, Sae Jung Na, Il Ki Hong, Jin Kyoung Oh, Yong An Chung, Tae-Sung Kim, Mijin Yun. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study. European Journal of Nuclear Medicine and Molecular Imaging 2018; 45(5): 720 doi: 10.1007/s00259-017-3880-4
|
| 38 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
|
| 39 |
Chen Zhang, Yaqi Li, Bohao Liu, Chao Ning, Yimin Li, Ying Wang, Zhuan Li. Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.813233
|
| 40 |
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies. Journal of Gastrointestinal Cancer 2018; 49(3): 227 doi: 10.1007/s12029-018-0121-4
|
| 41 |
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
|